Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
8.49
-0.28 (-3.19%)
At close: Mar 9, 2026, 4:00 PM EDT
8.49
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Karyopharm Therapeutics Employees
Karyopharm Therapeutics had 228 employees as of December 31, 2025. The number of employees decreased by 51 or -18.28% compared to the previous year.
Employees
228
Change (1Y)
-51
Growth (1Y)
-18.28%
Revenue / Employee
$640,645
Profits / Employee
-$859,820
Market Cap
155.83M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 174 |
| Zentalis Pharmaceuticals | 166 |
| Fate Therapeutics | 161 |
| Caribou Biosciences | 147 |
| Rani Therapeutics Holdings | 106 |
| Immunic | 90 |
| Tonix Pharmaceuticals Holding | 81 |
| Milestone Pharmaceuticals | 33 |
KPTI News
- 6 days ago - Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewsWire
- 24 days ago - Karyopharm Therapeutics Inc. (KPTI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress - PRNewsWire
- 4 weeks ago - Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - PRNewsWire
- 2 months ago - Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026 - PRNewsWire
- 3 months ago - Karyopharm to Participate in Baird's Biotech Discovery Series - PRNewsWire
- 3 months ago - Karyopharm to Participate at the Piper Sandler 37th Annual Healthcare Conference - PRNewsWire
- 4 months ago - Karyopharm Therapeutics Inc. (KPTI) Q3 2025 Earnings Call Transcript - Seeking Alpha